{
    "code": "52027986",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027986",
    "time": "2021-07-23 04:41:47",
    "許可證字號": "衛部藥輸字第027986號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/11\/09",
    "發證日期": "109\/11\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202798601",
    "中文品名": "億珂膜衣錠140毫克",
    "英文品名": "Imbruvica Film-Coated Tablets 140 mg",
    "適應症": "1.被套細胞淋巴瘤：適用於先前曾接受至少一種療法治療的被套細胞淋巴瘤 Mantle Cell Lymphoma(MCL)成年病人。\r\n2.慢性淋巴球性白血病\/小淋巴球性淋巴瘤：治療慢性淋巴球性白血病Chronic Lymphocytic Leukemia (CLL)\/小淋巴球性淋巴瘤Small Lymphocytic Lymphoma (SLL)成年病人。\r\n3.17p缺失性之慢性淋巴球性白血病\/小淋巴球性淋巴瘤：治療患有17p缺失性之慢性淋巴球性白血病Chronic Lymphocytic Leukemia(CLL)\/小淋巴球性淋巴瘤(SLL)的成年病人。\r\n4.Waldenström氏巨球蛋白血症：治療Waldenström氏巨球蛋白血症 (Waldenström’s macroglobulinemia(WM) )的成年病人 。\r\n5.邊緣區淋巴瘤：治療須接受全身性治療且先前曾接受至少一種抗CD20療法的邊緣區淋巴瘤Marginal Zone Lymphoma (MZL)成年病人。\r\n6.慢性移植體抗宿主疾病：治療使用一線或多線全身性療法治療失敗後的慢性移植體抗宿主疾病chronic Graft-Versus-Host Disease (cGVHD)成年病人。",
    "劑型": "116膜衣錠",
    "包裝": "8-1000錠鋁箔(PVC-PCTFE\/Aluminum Foil)盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新劑型",
    "監視期限": "",
    "主成分略述": "Ibrutinib",
    "限制項目": "02輸　入 1L監視中新藥",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0263000  CILAG AG",
            "製造廠廠址": "HOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "貼標廠"
        },
        {
            "製造廠名稱": "FIT0332000  JANSSEN-CILAG S.P.A.",
            "製造廠廠址": "VIA C. JANSSEN 04100 BORGO S. MICHELE-LATINA, ITALY",
            "製造廠公司地址": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE ITALY",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013005100",
            "成分名稱": "Ibrutinib",
            "含量描述": "",
            "含量": "140.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "[打樣版]億珂膜衣錠_仿單v2101_20201127-110-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027986&Seq=001&Type=9"
        },
        {
            "title": "億珂膜衣錠140毫克_鋁箔-110-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027986&Seq=005&Type=8"
        },
        {
            "title": "億珂膜衣錠140mg_30tab Box v01_(i_b_1045_v1)_20201127-110-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027986&Seq=004&Type=8"
        },
        {
            "title": "億珂膜衣錠140mg_28tab Box v01_(i_b_1045_v1)_20201127-110-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027986&Seq=003&Type=8"
        },
        {
            "title": "億珂膜衣錠140mg_14tab Wallet v01_20210209-110-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027986&Seq=002&Type=8"
        },
        {
            "title": "億珂膜衣錠140mg_10tab Wallet v01_(i_o_038-10tab_v3)_20210209-110-02-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027986&Seq=001&Type=8"
        }
    ]
}